HUM
45
2
CRM
44
2
RCL
58
3
CME
55
3
WHR
32
-3
DUK
34
2
USB
35
-4
BXP
34
-4
CNP
54
2
DTE
49
-5
LUV
43
4
KLAC
57
-4
WAT
47
-2
CI
52
-7
THC
68
-2
MMC
50
2
ORCL
59
-3
CMS
53
3
CA
12
4
NEE
42
4
HUM
45
2
CRM
44
2
RCL
58
3
CME
55
3
WHR
32
-3
DUK
34
2
USB
35
-4
BXP
34
-4
CNP
54
2
DTE
49
-5
LUV
43
4
KLAC
57
-4
WAT
47
-2
CI
52
-7
THC
68
-2
MMC
50
2
ORCL
59
-3
CMS
53
3
CA
12
4
NEE
42
4
Financhill
Back

Catalyst Pharmaceuticals Vs. Akero Therapeutics Industry Stock Comparison

Sell
42

CPRX
Catalyst Pharmaceuticals

Last Price:
15.34
Seasonality Move:
5.15%
Sell
28

AKRO
Akero Therapeutics

Last Price:
20.53
Seasonality Move:
19.37%
Sell
42
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $15.34. The Score for CPRX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
28
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $20.53. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $15.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing selling pressure, which indicates risk of future bearish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $20.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 46.76 Sell
Chaikin Money Flow: -1373778 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.35 - 16.25) Sell
Bollinger Bands (100): (13.98 - 16.18) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.14 Sell
Relative Strength Index (14 RSI): 31.06 Sell
Chaikin Money Flow: -466037 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (22.03 - 25.77) Sell
Bollinger Bands (100): (19.59 - 26.15) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.62 Sell
20-day SMA: 15.67 Sell
50-day SMA: 15.32 Buy
200-day SMA: 14.14 Buy
8-day EMA: 15.57 Sell
20-day EMA: 15.63 Sell
50-day EMA: 15.44 Sell
200-day EMA: 14.56 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 21.92 Sell
20-day SMA: 23.23 Sell
50-day SMA: 24.56 Sell
200-day SMA: 29.56 Sell
8-day EMA: 21.85 Sell
20-day EMA: 23.1 Sell
50-day EMA: 23.86 Sell
200-day EMA: 27.89 Sell

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.20 per share, and an increase next year of $0.43 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.36 per share, a decrease next quarter of $0.16 per share, a decrease this year of $1.11 per share, and a decrease next year of $0.63 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):